3300th ACST-2 patient recruited by National Scientific Center of Surgery Kazakhstan - Congratulations!
Congratulations to Istituto Auxologico Italiano for recruiting the 3200th ACST2 patient!
Congratulations to Mazovian Brodnowski Hospital for recruiting the 3150th ACST2 patient!
ACST-2's 6th Collaborators Meeting
Valencia, Spain
3600th ACST-2 patient recruited by St. Anna University Hospital Ferrara - Congratulations!
Newest Diamond Site Santa Maria Hospital, Reggio Emilia
Newest Diamond Site Santa Maria Hospital, Reggio Emilia
Congratulations on reaching 100 participants Santa Maria Hospital, Reggio Emilia!

Recruitment for the trial is now closed.

Follow up will be continuing for the future. We look forward to having the first results in ACST-2 later this year (2021).

ACST-2 (ISRCTN21144362) is an international randomised trial, coordinated by The ACST-2 office at The University of Oxford, comparing carotid endarterectomy (CEA) with carotid stenting (CAS) for long-term stroke prevention.

Patients in ACST-2 have tight asymptomatic carotid stenosis. We are comparing both the immediate hazards of the procedures when carried out by experienced doctors and the subsequent stroke rates over the next 5 to 10 years.

Message from the Chief Investigators:

 Follow ACST-2


Link to previous randomisations


Online or over the phone

+44 (0) 1865 28 77 00

General queries

Tel: +44 (0)1865 61 79 79

E-mail: acst@nds.ox.ac.uk